Sunshine Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sunshine Biopharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-16 | $-9.94 | $-7.40 | -34.3 % |
Mar 2024 | 2024-05-20 | $-40.00 | $-160.00 | 75.0 % |
Dec 2023 | 2024-03-28 | $-120.00 | $-60.00 | -100.0 % |
Sep 2023 | 2023-11-13 | $-80.00 | $-120.00 | 33.3 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-05 | $8.44M | $11.80M | -28.5 % |
Jun 2024 | 2024-08-16 | $9.30M | $9.00M | 3.37 % |
Mar 2024 | 2024-05-20 | $7.54M | $7.00M | 7.73 % |
Dec 2023 | 2024-03-28 | $7.68M | $6.10M | 25.9 % |
Sunshine Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3.
Sunshine Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was $-0.94, which missed the estimate of $0.00.
Sunshine Biopharma ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 5, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.